WCCT Global, an Altasciences company
– A Full-Service Early Phase CRO
WCCT Global, an Altasciences company, is a full-service early phase contract research organization (CRO) for the pharmaceutical, biotechnology and medical device industries. We are specialized regulatory and clinical development professionals who offer an innovative, agile and collaborative approach to every program we deliver.
Our Mission: To achieve our Sponsors’ Early Phase clinical objectives of advancing global health. This is accomplished through the development of a scientifically-informed time and budget-sensitive design; and with clinical trial research service execution that delivers high quality data, a superior client experience, and a volunteer-centric approach to care.
Phase 1 Unit
With 80,000 sq. ft. and 180 beds, our Cypress, CA clinical pharmacology unit (CPU) provides accommodations and clinical trial space for Phase 1 studies. Beyond standard Phase 1 capabilities, the unit has a number of specialized offerings to add further value to your development program:
Areas of Expertise
WCCT Global, an Altasciences company, offers U.S. and international sponsors access to an expanded breadth of clinical research offerings. Our emphasis is on overseeing and executing early phase trials in healthy volunteers and special populations. We have extensive experience with Phase 1 clinical trials, including first-in-human (FIH), SAD/MAD, PK/PD, BA/BE, and devices. Our focus includes Ethnobridging, First-in-Human, Infectious Disease & Vaccines, Ophthalmology, Women’s Health and Nicotine/Tobacco trials. We are an industry-leader in conducting Asian Ethnic Bridging studies (specifically in Japanese volunteers), at our Phase 1 Unit in Cypress, CA.
Our talented team of clinical experts delivers exceptional results by using innovative volunteer recruitment and retention solutions. We recruit unique target populations at our Phase 1 Unit and do so while keeping volunteer safety and comfort paramount in our service plan.
To add further value to our partners’ clinical programs, WCCT has established partnerships with various physicians local to our Phase 1 Unit in order to provide support on studies involving patient populations or requiring procedures specific to certain therapeutic areas. These physicians collaborate with us on:
- General consulting
- Protocol input
- Medical monitoring
- Patient recruitment
- Serving as PI/Sub-Investigator
- Performing procedures and evaluations
Around the world, WCCT is well-positioned to conduct trials of any size or complexity.
As part of WCCT, this specialized oncology CRO provides enhanced global research offerings.
We have extensive experience in biopharma and CRO across multiple therapeutic disciplines.
Board of Directors
Ensuring the continued success of WCCT with operational insight, guidance and depth of experience.